Blue Horseshoe Stocks: EXAD Review, Options & More

Experience Art & Design, Inc. EXAD – Impressive Run Continues

Yesterday morning, we were just updating readers on the call we made last Monday on EXAD at a low of .0009. It had subsequently run up to a high of .0024 (+167%) and we were congratulating folks who latched on for a nice profit.

We went on to mention that the stock was “exhibiting momentum-play characteristics” and that we’d continue to be interested if it could maintain support above .0015 on any pullbacks. Ultimately, there was no pullback. EXAD opened at Friday’s high and closing price of .0024, and took off on another bullish session that took it to an impressive new high of .0039; an intraday pop of 62%.

It closed at its high for the second straight session, and pushed our overall observed range in just a week’s time to 333%  As long as the stock continues to register higher base levels of support, we’ll remain interested in what has concisely demonstrated itself to be an extreme momentum-mover!


Shire plc SHPG – Options Idea

We also want to follow up on our options trading idea that we floated in yesterday’s premarket report, the SHPG Weekly $175-180 Calls. We said that we’d have them on watch throughout the course of the week, and would just like to reiterate that this morning.

We’re seeing a notable gap-up in early trading to day that should begin to fuel healthy observed gains for our highlighted contracts.



ChromaDex Corp CDXC

We have an interesting little story that has unfolded for CDXC inside of the past 24 hours. Yesterday a report and “Shareholder Alert” was published that effected a steep decline which you can very plainly see on the included chart.

Frank L. Jaksch, CEO of ChromaDex immediately responded, alleging that “The report appears to be a blatant and transparent attempt by a shortseller or shortsellers to profit from an immediate and precipitous decline in the company’s share price through the use of an opinion piece published anonymously and laden with misinformation…”

Even if the report contained elements of truth, the sharp selloff which occurred yesterday seems to be an over-reaction. We’ll have CDXC on recovery watch in coming sessions.


Extended Watchlist:
ELED, BHGI, RVUE, FTEK,
CUR(Gap to fill to .55)